Warning and Advisories for Healthcare Providers > Letters to Healthcare Providers

Letters to Healthcare Providers   Safety labeling changes and postmarket study requirements for extended-release and long-acting opioid analgesics (Letters to Healthcare Professionals)       Attachment: Safety labeling changes and postmarket study requirements.pdf   Related Information: The United Kingdom: Prolonged-release opioids: Removal of indication for relief ... Posted 2025-03-13 Prolonged-release opioids: Removal of indication for relief of post-operative pa... Posted 2025-03-13 The United States: FDA approves safety labeling changes for opioid pain medicine... Posted 2023-12-20 The United States: FDA updates prescribing information for all opioid pain medic... Posted 2023-04-14 FDA updates prescribing information for all opioid pain medicines to provide add... Posted 2023-04-14 Australia: Prescription opioids: Information for health professionals Posted 2020-10-03 The United Kingdom: Opioids: risk of dependence and addiction Posted 2020-09-24 Australia: Prescription opioids: Upcoming changes to reduce harm Posted 2019-08-23 Canada: Information Update - Label changes for controlled-release opioid pain me... Posted 2014-08-19 The United States: FDA announces safety labeling changes and postmarket study re... Posted 2013-09-11